Singapore markets open in 48 minutes

Acutus Medical, Inc. (AFIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.7254-0.0146 (-1.97%)
At close: 04:00PM EDT
0.7250 -0.00 (-0.06%)
After hours: 04:07PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 21.65M
Enterprise value 5.91M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)1.17
Price/book (mrq)0.49
Enterprise value/revenue 0.33
Enterprise value/EBITDA -0.21

Trading information

Stock price history

Beta (5Y monthly) 0.88
52-week change 3-16.76%
S&P500 52-week change 313.12%
52-week high 31.9600
52-week low 30.4000
50-day moving average 30.6013
200-day moving average 30.9323

Share statistics

Avg vol (3-month) 3108.32k
Avg vol (10-day) 388.72k
Shares outstanding 529.26M
Implied shares outstanding 629.26M
Float 822.79M
% held by insiders 14.26%
% held by institutions 137.45%
Shares short (14 Sept 2023) 4323.1k
Short ratio (14 Sept 2023) 43.58
Short % of float (14 Sept 2023) 41.13%
Short % of shares outstanding (14 Sept 2023) 41.10%
Shares short (prior month 14 Aug 2023) 4201.33k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Jun 2023


Profit margin -221.31%
Operating margin (ttm)-416.11%

Management effectiveness

Return on assets (ttm)-39.37%
Return on equity (ttm)-66.41%

Income statement

Revenue (ttm)18.06M
Revenue per share (ttm)0.63
Quarterly revenue growth (yoy)29.80%
Gross profit (ttm)-15.55M
EBITDA -69.58M
Net income avi to common (ttm)-39.98M
Diluted EPS (ttm)-1.4600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)54.52M
Total cash per share (mrq)1.86
Total debt (mrq)38.78M
Total debt/equity (mrq)88.66%
Current ratio (mrq)4.79
Book value per share (mrq)1.50

Cash flow statement

Operating cash flow (ttm)-65.42M
Levered free cash flow (ttm)-49.59M